How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 301–400 of 1,008
The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives
Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 71
Fan, H.-H., Zhu, L.-B., Li, T., Zhu, H. F., Wang, Y., Ren, X., Hu, B., Huang, C.-P., Zhu, J., & Zhang, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.004 · Cited by 81
Beier, E. E., Neal, M., Alam, G., Edler, M., Wu, L.-J., & Richardson, J. R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.009 · Cited by 74
“Based on this, macrophages and microglia can become activated towards more of a pro- or anti-inflammatory phenotype, oversimplified as M1 or M2, respectively (Cherry et al., 2014; Ransohoff, 2016a; Tang and Le, 2016).”
BackgroundAzetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase
Butler, C. R., Beck, E. M., Harris, A. R., Huang, Z., McAllister, L. A., Ende, C. W. A., Fennell, K. F., Foley, T. L., Fonseca, K. R., Hawrylik, S. J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01531 · Cited by 76
Chausse, B., Lewen, A., Poschet, G., & Kann, O. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.052 · Cited by 75
A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis
Mifflin, L., Hu, Z., Dufort, C., Hession, C. C., Walker, A. J., Niu, K., Zhu, H., Liu, N., Liu, J. S., Levin, J. Z., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025102118 · Cited by 75
“N has been recognized as an important pathological mechanism underpinning many neurodegenerative and neuropsychiatric conditions, ranging from acute insults such as stroke, to neurodevelopmental alterations as in autism and schizophrenia, to chronic neurodegenerative disorders such as multiple sclerosis (MS), amyotrop…”
BackgroundThe Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ruiz-Iglesias, A., & Mañes, S. (2021) · Cancers · doi:10.3390/cancers13071488 · Cited by 91
“However, MPC inhibition provides neuroprotection in PD by targeting the mTOR pathway [109], which prevents neuroinflammation [110] and protects primary neurons from death caused by”
BackgroundChen, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108394 · Cited by 82
Quansah, E., Peelaerts, W., Langston, J. W., Simon, D. K., Colca, J., & Brundin, P. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0260-x · Cited by 75
“Neuroinflammation is considered to play a major role in the pathophysiology of PD [62, 63].”
BackgroundTRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation
Li, M., Zhang, D., Ge, X., Zhu, X., Zhou, Y., Zhang, Y., Peng, X., & Shen, A. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.02.005 · Cited by 71
Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia
Kaviarasi, S., Yuba, E., Harada, A., & Krishnan, U. M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.031 · Cited by 78
Lau, D. H. W., Hartopp, N., Welsh, N. J., Mueller, S., Glennon, E. B., Mórotz, G. M., Annibali, A., Gomez-Suaga, P., Stoica, R., Paillusson, S., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0022-7 · Cited by 73
Bussi, C., Peralta Ramos, J. M., Arroyo, D. S., Gallea, J. I., Ronchi, P., Kolovou, A., Wang, J. M., Florey, O., Celej, M. S., Schwab, Y., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.226241 · Cited by 74
“The major function of microglia is to maintain homeostasis and normal function of the CNS, both during development and in response to CNS injury (Ransohoff, 2016).”
BackgroundHassan, A. T., Kandel, R. S., Mishra, R., Gautam, J., Alaref, A. A., & Jahan, N. (2020) · Cureus · doi:10.7759/cureus.9853 · Cited by 79
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
Giménez, V. M. M., Heras, N. D. L., Lahera, V., Tresguerres, J. A. F., Reiter, R. J., & Manucha, W. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888292 · Cited by 83
“In AD patients, along with senile plaques (β-amyloid peptides) and neurofibrillary tangles (tau/phosphorylated tau proteins), inflammatory processes, oxidative stress, mitochondrial dysfunction, and the appearance of reactive gliosis (Ransohoff, 2016) are also evident.”
BackgroundWatson, P. M. D., Kavanagh, E., Allenby, G., & Vassey, M. (2017) · SLAS Discovery · doi:10.1177/2472555217691450 · Cited by 74
“Glial inflammatory genes, the innate immune system, and neuroinflammation in particular are currently highly active areas of academic research.(30) All of the above have spurred a resurgence in interest from pharmaceutical and biotechnology companies in astrocytes and microglia as target cell types for high-throughput…”
BackgroundRNA-seq and network analysis reveal unique glial gene expression signatures during prion infection
Carroll, J. A., Race, B., Williams, K., Striebel, J., & Chesebro, B. (2020) · Molecular Brain · doi:10.1186/s13041-020-00610-8 · Cited by 66
Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Wang, J.-J., Liu, C., Shan, K. Y., Liu, B.-H., Li, X., Zhang, S.-J., Zhou, R.-M., Dong, R., Yan, B., & Sun, X.-H. (2018) · Theranostics · doi:10.7150/thno.25156 · Cited by 75
“They have several common pathological features, such as oxidative stress, inflammation, and hypometabolism [3].”
BackgroundNeuroprotective protein hydrolysates from hemp ( Cannabis sativa L.) seeds
Rodríguez-Martín, N. M., Toscano, R., Villanueva-Lazo, A., Pedroche, J., Millán, F., la Paz, S. M., & Millán-Linares, M. C. (2019) · Food & Function · doi:10.1039/c9fo01904a · Cited by 86
Mann, C. N., Devi, S. S., Kersting, C. T., Bleem, A. V., Karch, C. M., Holtzman, D. M., & Gallardo, G. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm4107 · Cited by 73
“Reactive astrocytes, or astrogliosis, are a well-known feature of neurodegeneration and are commonly classified by an increase in glial fibrillary acidic protein (GFAP), hypertrophy of the cell body, and increased secretion of inflammatory factors (6, 12).”
BackgroundTheoharides, T. C., & Kempuraj, D. (2023) · Cells · doi:10.3390/cells12050688 · Cited by 86
Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
Stancu, I. C., Lodder, C., Botella Lucena, P., Vanherle, S., Gutiérrez de Ravé, M., Terwel, D., Bottelbergs, A., & Dewachter, I. (2022) · Glia · doi:10.1002/glia.24160 · Cited by 72
Nerve Growth Factor modulates LPS - induced microglial glycolysis and inflammatory responses
Fodelianaki, G., Lansing, F., Bhattarai, P., Troullinaki, M., Zeballos, M. A., Charalampopoulos, I., Gravanis, A., Mirtschink, P., Chavakis, T., & Alexaki, V. I. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.02.023 · Cited by 70
Zheng, Y., Zhang, J., Zhao, Y., Zhang, Y., Zhang, X., Guan, J., Liu, Y., & Fu, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107422 · Cited by 76
Düsedau, H. P., Steffen, J., Figueiredo, C. A., Boehme, J. D., Schultz, K., Erck, C., Körte, M., Faber‐Zuschratter, H., Smalla, K., Dieterich, D. C., et al. (2021) · mBio · doi:10.1128/mbio.01776-21 · Cited by 83
“As a consequence, synergistic effects of multiple infections acquired throughout life could lead to a previously unappreciated contribution to the development of chronic neuroinflammation, contributing to the initiation and progression of neurodegenerative diseases such as in AD or Parkinson disease (PD) (97, 98).”
BackgroundRAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
Sbai, O., Djelloul, M., Auletta, A., Ieraci, A., Vascotto, C., & Perrone, L. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04758-0 · Cited by 72
“Neuroinflammation mediated by microglia plays a key role in AD pathogenesis [4].”
Anti-inflammatory role of GM1 and other gangliosides on microglia
Galleguillos, D., Wang, Q., Steinberg, N., Zaidi, A. K., Shrivastava, G., Dhami, K., Daskhan, G. C., Schmidt, E. N., Dworsky-Fried, Z., Giuliani, F., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02374-x · Cited by 78
Wu, H., Zhang, T., Li, N., & Gao, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.023 · Cited by 76
Ex vivo gene therapy for the treatment of neurological disorders
Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.003 · Cited by 88
Jones, J. D., Rahmani, E., Garcia, E., & Jacobs, J. P. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.01.009 · Cited by 70
“Each of these mechanisms has the potential to accelerate disease development and induce motor and non-motor symptoms, in particular by promoting neuroinflammation and consequent neurodegeneration [13].”
BackgroundMicroglia mediated neuroinflammation in autism spectrum disorder
Liao, X., Yang, J., Wang, H., & Li, Y. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.013 · Cited by 88
dos Santos, M. G., Schimith, L. E., André‐Miral, C., Muccillo-Baisch, A. L., Arbo, B. D., & Hort, M. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00450-x · Cited by 87
E. Hirbec, H., Noristani, H. N., & Perrin, F. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00227 · Cited by 71
“However, this view has been recently challenged and it is now accepted that morphological alteration/activation does not necessarily reflect microglia function (or dysfunction; Perry, 2010; Ransohoff, 2016).”
BackgroundStem cell therapy for neurological disorders: A focus on aging
Nguyen, H., Zarriello, S., Coats, A. B., Nelson, C., Kingsbury, C., Gorsky, A., Rajani, M., Neal, E. G., & Borlongan, C. V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.011 · Cited by 80
“Many of these hallmarks contribute a significant role in the pathology and the progression of neurological disorders (Lopez-Otin et al., 2013; Ransohoff, 2016; Wyss-Coray, 2016).”
BackgroundThe Role of Circular RNAs in Immune-Related Diseases
Xie, R., Zhang, Y., Zhang, J., Li, J., & Zhou, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00545 · Cited by 73
Chen, Z., Haider, A., Chen, J., Xiao, Z., Gobbi, L. B., Honer, M., Grether, U., Arnold, S. E., Josephson, L., & Liang, S. H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01571 · Cited by 72
Rothammer, N., Woo, M. S., Bauer, S., Binkle-Ladisch, L., Di Liberto, G., Egervari, K., Wagner, I., Haferkamp, U., Pless, O., Merkler, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm5500 · Cited by 69
“In this regard, chronic progressive MS is reminiscent of primary neurodegenerative diseases that are accompanied by low-grade inflammation, such as Parkinson’s or Alzheimer’s disease ( 5 ).”
Aragón-González, A., Shaw, P. J., & Ferraiuolo, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315271 · Cited by 83
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
Kozela, E., Juknat, A., & Vogel, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081669 · Cited by 83
“Thus, the pharmacological modulation of reactive astrocytes has been proposed as a tool to blunt neuronal damage and to slow the course of brain diseases [5,6].”
Decandia, D., Gelfo, F., Landolfo, E., Balsamo, F., Petrosini, L., & Cutuli, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065921 · Cited by 70
Sen, T., Saha, P., Jiang, T., & Sen, N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916895117 · Cited by 68
“However, AKT can be sulfhydrated under inflammatory conditions, which are present in all of the neurodegenerative disorders, including AD, Parkinson’s disease, traumatic brain injury, and multiple sclerosis (57, 58).”
BackgroundLiu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., Yang, W., Xie, H., Lü, Z., Chen, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.01.010 · Cited by 80
“BV2 microglia (Shanghai Institutes for Biological Sciences, China) were cultured in DMEM (Corning, USA) supplemented with 10 % (v/v) FBS (Sigma, Australia) at 37 ◦ C, under a humidified atmosphere containing 5 % CO 2 .”
BackgroundInfluentialHidalgo‐Lanussa, O., Ávila-Rodriguez, M., Báez-Jurado, E., Zamudio-Rodriguez, J. A., Echeverría, V., García‐Segura, L. M., & Barreto, G. E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0777-y · Cited by 70
Trehalose against Alzheimer's Disease: Insights into a Potential Therapy
Khalifeh, M., Read, M. I., Barreto, G. E., & Sahebkar, A. (2020) · BioEssays · doi:10.1002/bies.201900195 · Cited by 68
Quarta, A., Berneman, Z. N., & Ponsaerts, P. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.023 · Cited by 71
Tesi, N., van der Lee, S. J., Hulsman, M., Jansen, I. E., Stringa, N., van Schoor, N. M., Scheltens, P., van der Flier, W. M., Huisman, M., Reinders, M. J. T., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01018-7 · Cited by 67
“13 consequence of β-amyloid metabolism.[58, 59] In addition, previous studies showed that healthy immune and 359 metabolic systems are associated with longer and healthier lifespan.”
ResultNeuroinflammation Treatment via Targeted Delivery of Nanoparticles
Cerqueira, S. R., Ayad, N. G., & Lee, J. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.576037 · Cited by 77
“…has been used to describe different cellular and molecular pathological phenomena that can encompass activation of CNS-resident cells, CNS infiltration by circulating leukocytes, and production of inflammatory mediators in the CNS environment (Waisman et al., 2015; Ransohoff, 2016).”
BackgroundGo, J., Chang, D.-H., Ryu, Y.-K., Park, H.-Y., Lee, I.-B., Noh, J.-R., Hwang, D. Y., Kim, B.-C., Kim, K.-S., & Lee, C.-H. (2021) · Nutrition Research · doi:10.1016/j.nutres.2020.12.010 · Cited by 67
Wang, P., Luo, M., Zhou, W., Jin, X., Xu, Z., Yan, S., Li, Y., Xu, C., Cheng, R., Huang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814239 · Cited by 78
“Recently, neuroinflammation has attracted increasing attention due to its potential in the development of novel molecular biomarkers and targeted therapies (46, 47).”
BackgroundYang, L., Cui, Y., Liang, H., Li, Z., Wang, N., Wang, Y., & Zheng, G. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c06283 · Cited by 73
Raghavan, A., Rimmelin, D., Fitch, K. V., & Zanni, M. V. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0366-8 · Cited by 73
An update on human astrocytes and their role in development and disease
de Majo, M., Koontz, M., Rowitch, D. H., & Ullian, E. M. (2020) · Glia · doi:10.1002/glia.23771 · Cited by 70
“Similarly to ALS and AD, neuroinflammation plays an important role in FTLD. PET imaging, in fact, revealed increased level of translocator protein (TSPO, a biomarker of microgliosis) in numerous brain regions associated with the disease (Cagnin, Rossor, Sampson, Mackinnon, & Banati, 2004).”
BackgroundInfluentialZhong, Z., Chen, W., Gao, H., Che, N., Xu, M., Yang, L., Zhang, Y., & Ye, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03411-0 · Cited by 66
Translational studies identify long-term impact of prior neonatal pain experience
Walker, S. M. (2017) · Pain · doi:10.1097/j.pain.0000000000000784 · Cited by 70
Neurological and psychiatric associations in bullous pemphigoid—more than skin deep?
Försti, A., Huilaja, L., Schmidt, E., & Tasanen, K. (2017) · Experimental Dermatology · doi:10.1111/exd.13401 · Cited by 67
Raikwar, S. P., Thangavel, R., Dubova, I., Selvakumar, G. P., Ahmed, M. E., Kempuraj, D., Zaheer, S. A., Iyer, S. S., & Zaheer, A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1068-y · Cited by 73
Alpha-Synuclein Nitration and Its Implications in Parkinson’s Disease
He, Y., Yu, Z., & Chen, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00288 · Cited by 68
Yang, Y., He, Z., Xing, Z., Zuo, Z., Yuan, L., Wu, Y., Jiang, M. H., Qi, F., & Yao, Z. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01741-4 · Cited by 74
Trojan Horse Delivery of 4,4′‐Dimethoxychalcone for Parkinsonian Neuroprotection
Zhang, W., Chen, H., Ding, L., Gong, J., Zhang, M., Guo, W., Xu, P., Li, S., & Zhang, Y. (2021) · Advanced Science · doi:10.1002/advs.202004555 · Cited by 67
Respiratory disorders of Parkinson’s disease
Aquino, Y. C., Cabral, L. M., Miranda, N. C., Naccarato, M. C., Falquetto, B., Moreira, T. S., & Takakura, A. C. T. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00363.2021 · Cited by 74
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 63
“The neuroinflammation process is featured by the release of pro-inflammatory cytokines and chemokines, together with the activation of astrocytes and microglial cells (Ransohoff, 2016).”
BackgroundGlycosylation changes in inflammatory diseases
Groux‐Degroote, S., Cavdarli, S., Uchimura, K., Allain, F., & Delannoy, P. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.008 · Cited by 69
Steroids and Alzheimer’s Disease: Changes Associated with Pathology and Therapeutic Potential
Akwa, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134812 · Cited by 62
“Abnormalities of Aβ and tau cause activation of microglia and astrocytes, and trigger the innate immune system by releasing proinflammatory mediators (for reviews [119,120]).”
BackgroundDual leucine zipper kinase is required for mechanical allodynia and microgliosis after nerve injury
Wlaschin, J. J., Gluski, J. M., Nguyen, E. K., Silberberg, H., Thompson, J. H., Chesler, A. T., & Pichon, C. E. L. (2018) · eLife · doi:10.7554/elife.33910 · Cited by 69
Castellano, J. M., Garcia-Rodriguez, S., Espinosa, J. M., Millán-Linares, M. C., Rada, M., & Perona, J. S. (2019) · Biomolecules · doi:10.3390/biom9110683 · Cited by 68
“A positive feedback loop between neuronal injury and inflammation is built, which triggers neuronal death pathways and activates other glial cells [1,46,47].”
BackgroundNeuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics
Gaetani, L., Bellomo, G., Parnetti, L., Blennow, K., Zetterberg, H., & Filippo, M. D. (2021) · Cells · doi:10.3390/cells10081930 · Cited by 69
“, infective, traumatic, vascular, or toxic insults) [4].”
Sarailoo, M., Afshari, S., Asghariazar, V., Safarzadeh, E., & Dadkhah, M. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00552-0 · Cited by 79
“…of glial cells chronically alternates the physiological function of the tau protein, inducing the activation of enzymes to phosphorylate tau, such as CDK5 and GSK-3β enzymes, giving way to the formation of NFTs, resulting in decreasing the neuronal capacity (Lull and Block 2010; Ransohoff 2016).”
BackgroundNebeling, F. C., Poll, S., Justus, L. C., Mittag, M., Steffen, J., Keppler, K., & Fuhrmann, M. (2023) · eLife · doi:10.7554/elife.83176 · Cited by 70
Zhang, H., Jin, B., & Faber, J. E. (2018) · Angiogenesis · doi:10.1007/s10456-018-9655-0 · Cited by 67
Ng, J., Barral, S., Barrigon, C. D. L. F., Lignani, G., Erdem, F. A., Wallings, R. L., Privolizzi, R., Rossignoli, G., Alrashidi, H., Heasman, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1564 · Cited by 63
“Given the established pathogenic role of neuroinflammation in neurodegenerative disorders (16), we used the in vitro mDA model to investigate the effect of proinflammatory cytokines in the context of DA toxicity secondary to extracellular DA accumulation (17–19).”
MethodPons‐Espinal, M., Blasco-Agell, L., Fernández‐Carasa, I., Andrés‐Benito, P., di Domenico, A., Richaud‐Patín, Y., Baruffi, V., Marruecos, L., Espinosa, L., Garrido, A., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.163359 · Cited by 77
Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice
Deguise, M., Repentigny, Y. D., McFall, E. R., Auclair, N., Sad, S., & Kothary, R. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw434 · Cited by 65
“Neuroinflammation is a well-established contributor in neurodegenerative disorders (45).”
BackgroundKempuraj, D., Thangavel, R., Selvakumar, G. P., Ahmed, M. E., Zaheer, S. A., Raikwar, S. P., Zahoor, H., Saeed, D., Dubova, I., Giler, G., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1177-7 · Cited by 70
Nan, K., Han, Y., Fang, Q., Huang, C., Yu, L., Ge, W., Xiang, F., Tao, Y.-X., Cao, H., & Li, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.027 · Cited by 62
Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
Wang, L., Yu, X., Li, X., Zhao, Y., Wang, C., Wang, Z., & He, Z. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00316 · Cited by 66
“Additionally, in postmortem studies and animal models of PD, ROS and nitrogen species were found to be increased, which was accompanied by activation of microglia and reactive astrocytes (Herrero et al., 2015; Ransohoff, 2016).”
BackgroundHeritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis
Andersen, M. S., Bandres‐Ciga, S., Reynolds, R. H., Hardy, J., Ryten, M., Krohn, L., Gan‐Or, Z., Holtman, I. R., Pihlstrøm, L., & the International Parkinson's Disease Genomics Consortium (2021) · Annals of Neurology · doi:10.1002/ana.26032 · Cited by 60
Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
Braun, G. A., Dear, A. J., Sanagavarapu, K., Zetterberg, H., & Linse, S. S. (2022) · Chemical Science · doi:10.1039/d1sc02990h · Cited by 75
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 70
Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment
Wu, X., Wan, T., Gao, X., Fu, M., Duan, Y., Shen, X., & Guo, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.922331 · Cited by 66
“This finding is supported by the results of several necropsy analyses (Ransohoff, 2016b; Leyns and Holtzman, 2017).”
ResultLomartire, S., & Gonçalves, A. M. M. (2023) · Marine Drugs · doi:10.3390/md21050261 · Cited by 68
“Alzheimer’s disease (AD), frontotemporal lobar dementia (FTLD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) are some of the most common neurodegenerative diseases [33].”
BackgroundTrained innate immunity: Concept, nomenclature, and future perspectives
Netea, M. G., & Joosten, L. A. B. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.09.005 · Cited by 77
Microglial Interferon Signaling and White Matter
McDonough, A., Lee, R. V., & Weinstein, J. R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2307-8 · Cited by 60
“In many cases these encounters induce a transient classical ‘activation’ state in microglia with release of specific pro-inflammatory chemokines and cytokines [18–20] as well as marked morphological [13] and functional changes [16, 17].”
Tisato, V., Zuliani, G., Vigliano, M., Longo, G., Franchini, E., Secchiero, P., Zauli, G., Paraboschi, E. M., Singh, A. V., Serino, M. L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193867 · Cited by 61
Li, Y., Sibon, O. C. M., & Dijkers, P. F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1278-2 · Cited by 70
“Examining astrocytes in an in vivo model is key, given that their morphology and activity change when taken outside their physiological context (reviewed in [12]).”
BackgroundRoles for the adaptive immune system in Parkinson’s and Alzheimer’s diseases
Lindestam Arlehamn, C. S., Garretti, F., Sulzer, D., & Sette, A. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.07.004 · Cited by 60
Xu, M., Wang, L., Wu, S., Dong, Y., Xiu, C., Wang, S., Li, X., & Zou, C. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-680 · Cited by 67
“Glial cells, an important part of the nervous system, are essential in neuroinflammatory reactions (92-94).”
BackgroundGuo, X., Lei, M., Zhao, J., Wu, M., Ren, Z., Yang, X., Ouyang, C., Liu, X., Liu, C., & Chen, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1146960 · Cited by 59
“Neurodegeneration is partly contributed to the environment which is affected by cascading processes collectively termed neuroinflammation during disease (Ransohoff, 2016).”
BackgroundMacrophages and microglia in inflammation and neuroinflammation underlying different pain states
Ouyang, C., Luo, X., & Ji, R. (2023) · Medical Review · doi:10.1515/mr-2023-0034 · Cited by 74
Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03166-9 · Cited by 60
“In response to patho-gen infections or neurodegenerative disorders, reactive microglia mediate phagocytic uptake and the secretion of inflammatory cytokines and chemokines [30–32].”
BackgroundImmunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 63
Peng, S., Wang, C., Ma, J., Jiang, K., Jiang, Y., Gu, X., & Sun, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14110 · Cited by 60
“ABPPk attenuates microglia and astrocyte activation Chronic low-grade inflammation has been demonstrated as a principal causative factor for incidence of PD (Ransohoff, 2016).”
BackgroundLe Menn, G., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 60
“Both human studies and animal models concur to suggest an interrelationship between metabolic disease and neurodegenerative disorders (NDDs), such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and multiple sclerosis [4–9].”
BackgroundInfluentialDu, R., Zhou, Y., Xia, M., Lu, M., Ding, J., & Hu, G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1302-6 · Cited by 63
“Neuroinflammation is mediated predominantly by activated glial cells and is accompanied by the production of inflammatory cytokines [2].”
BackgroundNeuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 66
Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back
Haight, E. S., Forman, T. E., Cordonnier, S. A., James, M. L., & Tawfik, V. L. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004033 · Cited by 69
Entanglement of Genetics and Epigenetics in Parkinson’s Disease
van Heesbeen, H. J., & Smidt, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00277 · Cited by 59
Vagus nerve stimulation modulates hippocampal inflammation caused by continuous stress in rats
Namgung, U., Kim, K.-J., Jo, B.-G., & Park, J.-M. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02396-z · Cited by 59
Redox Biology in Neurological Function, Dysfunction, and Aging
Franco, R., & Vargas, M. R. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7509 · Cited by 68
“1) (5), but how redox signaling regulates these processes is far from being understood.”
BackgroundCellular Mechanisms Participating in Brain Repair of Adult Zebrafish and Mammals after Injury
Ghaddar, B., Lübke, L., Couret, D., Rastegar, S., & Diotel, N. (2021) · Cells · doi:10.3390/cells10020391 · Cited by 75
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.